IGFBP3 and central nervous system cancer: Chen et al. [7] demonstrated a higher expression of IGFBP3 in GBM, which was not only positively correlated with the degree of malignancy of gliomas, but also was associated with tumor histology and mutation status in isocitrate hydrogenase (IDH) 1 and 2.